April 17, 2017 13:09 UTC

China Proton Therapy Market & Forecast, 2021: Patients Treated at Proton Therapy Facility, Reimbursement Policy - Research and Markets

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the "China Proton Therapy Market & Forecast, Patients Treated at Proton Therapy Facility, Reimbursement Policy" report to their offering.

China Proton Therapy Market is expected to grow at a CAGR of 25% in future. China Proton Therapy Market is expected to triple by the end of 2021 from its current market in 2016.

Currently China has only two proton therapy facilities. However the scenario is going to make a drastic change in the next few years when China will have at least 6 new Proton Therapy Centers.

In this report we have studied the market in two parts: a) Actual Market and b) Untapped Market. The report also talks about list of all Operational and about to be opened Proton Therapy Facility. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

China Proton Therapy Market has been analyzed from four view points:

- China Proton Therapy Actual Market & Forecast (2009 - 2021)

- China Proton Therapy Untapped Market & Forecast (2009 - 2021)

- China Proton Therapy Treated Patient Numbers & Forecast (2009 - 2021)

- China Proton Therapy Untapped Patient Numbers & Forecast (2009 - 2021)

Key Companies Covered:

- IBA (Overview, Sales Analysis)

- Varian Medical Systems (Overview, Sales Analysis)

- Elekta (Overview, Sales Analysis)

- Shanghai Proton and Heavy Ion Center

- Wanjie (WPTC) Proton Therapy Center

Key Topics Covered:

1. Executive Summary

2. China Proton Therapy Market - Actual & Untapped Market

2.1 China - Proton Therapy Market & Forecast

2.2 China - Untapped Proton Therapy Market

3. China Proton Therapy Patient - Actual & Untapped Patients

3.1 China - Patient Treated with Proton Therapy Numbers & Forecast

3.2 China - Untapped Patients for Proton Therapy

4. China - List of Proton Therapy Centers (Operating, Under-Construction & Planning) Facilities

5. China - Proton Therapy Treated Patients by Centers

5.1 Wanjie (WPTC) Proton Therapy Center

5.2 Shanghai Proton and Heavy Ion Center

6. Proton Therapy - Reimbursement Policies

6.1 Proton Therapy Reimbursement Policies for Patients

6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

7. Components of a Standard Proton Therapy Center

7.1 Proton Accelerator

7.1.1 Synchrotrons (example: LLUMC at Loma Linda)

7.1.2 Cyclotrons (example: MGH Boston)

7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)

7.1.4 Linacs (Rome)

7.1.5 H-minus Synchrotrons

7.1.6 Separated Sector Cyclotrons

7.1.7 Super-conducting Cyclotrons

7.1.8 Fast Cycling Synchrotron

7.2 Beam Transport System

7.3 Beam Delivery System

7.3.1 The Passive Scattering Technique

7.3.2 Beam Scanning

7.4 Nozzle

7.4.1 Single Scattering

7.4.2 Double Scattering

7.4.3 Uniform Scanning Nozzle

7.4.4 Pencil Scanning Nozzle

7.5 Treatment Planning System

7.6 Image Viewers

7.7 Patient Positioning System (PPS)

7.8 Human Resource

8. Global Proton Therapy - Company Analysis (2010-2021)

9. Proton Therapy - Driving Factors

10. Proton Therapy - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/r88gbb/china_proton

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nuclear Medicine and Radiopharmacology


Source: Research and Markets